On October 30, 2017, the 9th IVD China Summit, sponsored by IVD branch of CAMDI, RSE and co-organized by Beijing Strong Biotechnologies, Inc., was held in Kunming Dianchi International Convention and Exhibition Center.
Since the launch in 2007, the IVD China Summit has been held eight times. The Summit has been at the leading edge of industry development in a macro level, attracting the government leaders, scientific research and clinical experts, enterprise elites to have discussion and communication. Relying on the CMEF platform, the Summit is intended to create a professional summit with highest level, newest content, maximum information, and most influence.

Xu Shan, Secretary-General of CAMDI

Zou Zuojun makes chairman address

Hao Xiaoke, vice chairman of Chinese Society of Laboratory Medicine, Chinese Association of Laboratory
Physician, Laboratory Medicine Specialized Committee of PLA Medical Science Committee

Mao Yuanli, vice chairman of China Society of Medical Laboratory Equipment

Chen Wenxiang, chairman of Chinese Association of Clinical Laboratory Management

Kang Xixiong, president of the Division of Clinical Biochemistry and Molecular Biology, CSBMB

Ge Shengxiang, secretary general of Strategic Alliance of In-vitro Diagnostic Innovation

Song Haibo, president of Medical Laboratory Branch of National Association of Health Industry and Enterprise Management

Wang Hualiang, chairman of Laboratory Medicine Committee of National Association of Health Industry and Enterprise Management

Zhu Yaoyi, president of In Vitro Diagnosis (IVD) Branch, CAMDI
The Summit was presided over by Xu Shan, Secretary-General of CAMDI and Zou Zuojun, president of Beijing Strong Biotechnologies, Inc. made an opening speech. And Hao Xiaoke, Mao Yuanli, Chen Wenxiang, Kang Xixiong, Ge Shengxiang, Song Haibo, Wang Hualiang, Zhu Yaoyi and other industry association leaders explained their respective platforms systematically and thoroughly.

Lai Shiqing, ombudsman of Department of System Reform, National Health and Family Planning Commission (NHFPC)

Zhu Yongfeng, director of supervision department of Department of System Reform, NHFPC

Song Haibo, president of Medical Laboratory Branch of National Association of Health Industry and Enterprise Management
The meeting was also supported by Roche and Taizhou Medical City.
